Agilent Technologies, Inc. (NYSE:A) Stock Holdings Trimmed by TD Private Client Wealth LLC

TD Private Client Wealth LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 36.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,996 shares of the medical research company's stock after selling 2,292 shares during the quarter. TD Private Client Wealth LLC's holdings in Agilent Technologies were worth $467,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. CIBC Private Wealth Group LLC grew its holdings in Agilent Technologies by 1.2% in the fourth quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock valued at $1,025,000 after purchasing an additional 87 shares during the last quarter. Western Pacific Wealth Management LP grew its holdings in Agilent Technologies by 15.2% in the first quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company's stock valued at $102,000 after purchasing an additional 115 shares during the last quarter. Bartlett & CO. Wealth Management LLC grew its holdings in Agilent Technologies by 5.1% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company's stock valued at $281,000 after purchasing an additional 116 shares during the last quarter. Brighton Jones LLC grew its holdings in Agilent Technologies by 2.6% in the first quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company's stock valued at $560,000 after purchasing an additional 121 shares during the last quarter. Finally, Pflug Koory LLC grew its holdings in Agilent Technologies by 3.9% in the first quarter. Pflug Koory LLC now owns 3,327 shares of the medical research company's stock valued at $389,000 after purchasing an additional 125 shares during the last quarter.

Agilent Technologies Stock Down 2.6%

A stock traded down $3.18 during midday trading on Monday, hitting $120.10. 2,022,465 shares of the company's stock were exchanged, compared to its average volume of 1,848,038. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The firm has a 50 day moving average price of $115.23 and a 200-day moving average price of $122.66. The stock has a market capitalization of $34.12 billion, a price-to-earnings ratio of 29.65, a price-to-earnings-growth ratio of 3.74 and a beta of 1.23.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.05. The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. Agilent Technologies's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.22 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.83%. Agilent Technologies's payout ratio is 24.44%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on A shares. Wells Fargo & Company decreased their price objective on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Barclays increased their price objective on Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a research note on Tuesday, June 24th. TD Cowen increased their price objective on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. Robert W. Baird decreased their price objective on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research note on Thursday, May 22nd. Finally, Wall Street Zen raised Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $139.77.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.